Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Variance-based sensitivity analysis of tuberculosis transmission models.
SUMNER, T; WHITE, RG;
2022
Journal of the Royal Society, Interface, (2022).19 196 10.1098/rsif.2022.0413.
Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
The OpenSAFELY Collaborative,; PARKER, EP K; Horne, EM F; Hulme, W; TAZARE, J; ZHENG, B; Carr, E; Loud, F; Lyon, S; MAHALINGASIVAM, V; MacKenna, B; Mehrkar, A; Scanlon, M; Santhakumaran, S; Steenkamp, R; GOLDACRE, B; Sterne, JA C; Nitsch, D; TOMLINSON, L; The LH&W NCS (or CONVALESCENCE) Collaborative,;
2022
medRxiv (2022). 10.1101/2022.11.16.22282396.
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
ZHENG, B; Green, AC A; TAZARE, J; Curtis, HJ; Fisher, L; Nab, L; SCHULTZE, A; MAHALINGASIVAM, V; PARKER, EP K; Hulme, WJ; Bacon, SC J; DeVito, NJ; Bates, C; Evans, D; Inglesby, P; Drysdale, H; Davy, S; Cockburn, J; Morton, CE; Hickman, G; Ward, T; Smith, RM; Parry, J; Hester, F; Harper, S; ... TOMLINSON, LA.
2022
BMJ (Clinical research ed.), (2022).379, 10.1136/bmj-2022-071932.
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
Jayawardana, S; WEERASURIYA, CK; Pelzer, PT; SEELEY, J; Harris, RC; Tameris, M; Tait, D; WHITE, RG; Asaria, M;
2022
npj Vaccines, (2022).7 1 10.1038/s41541-022-00554-1.
Considering equity in priority setting using transmission models: Recommendations and data needs.
Quaife, M; MEDLEY, GF; JIT, M; Drake, T; Asaria, M; Van Baal, P; Baltussen, R; Bollinger, L; BOZZANI, F; BRADY, O; Broekhuizen, H; Chalkidou, K; Chi, Y-L; Dowdy, DW; Griffin, S; Haghparast-Bidgoli, H; Hallett, T; Hauck, K; Hollingsworth, TD; MCQUAID, CF; Menzies, NA; Merritt, MW; Mirelman, A; Morton, A; RUIZ, FJ; ... Gomez, GB.
2022
Epidemics, (2022).41, 10.1016/j.epidem.2022.100648.
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design.
Benest, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 11 10.3390/vaccines10111838.
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low- and middle-income countries.
Portnoy, A; Clark, R; WEERASURIYA, C; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.10.29.22281678.
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
Rhodes, S; Smith, N; Evans, T; WHITE, R;
2022
Vaccine, (2022).40 49 10.1016/j.vaccine.2022.10.012.
Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
Echeverria-Londono, S; Hartner, A-M; Li, X; Roth, J; Portnoy, A; SBARRA, AN; ABBAS, K; Ferrari, M; FU, H; JIT, M; Ferguson, NM; Gaythorpe, KA M;
2022
Vaccine, (2022).40 47 10.1016/j.vaccine.2022.09.049.
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel.
Miner, MD; Hatherill, M; Mave, V; Gray, GE; Nachman, S; Read, SW; WHITE, RG; Hesseling, A; Cobelens, F; Patel, S; Frick, M; Bailey, T; Seder, R; Flynn, J; Rengarajan, J; Kaushal, D; Hanekom, W; Schmidt, AC; Scriba, TJ; Nemes, E; Andersen-Nissen, E; Landay, A; Dorman, SE; Aldrovandi, G; Cranmer, LM; ... Churchyard, G.
2022
The lancet. HIV, (2022).9 11 10.1016/S2352-3018(22)00255-7.